Development of a Humanized VHH Based Recombinant Antibody Targeting Claudin 18.2 Positive Cancers

Development of a Humanized VHH Based Recombinant Antibody Targeting Claudin 18.2 Positive Cancers

Claudin 18.2 (CLDN18.2), a tight junction (TJ) family protein controlling molecule exchange between cells, is frequently over-expressed in gastric cancer, pancreatic adenocarcinomas and in a fraction of non–small cell lung cancer cases. The tumor properties indicate that CLDN18.2 could be an attract...

Full description

Bibliographic Details
Main Authors: Weixiang Zhong, Yimin Lu, Zhe Ma, Yinjun He, Yongfeng Ding, Gaofeng Yao, Zhenxing Zhou, Jiali Dong, Yongliang Fang, Weiqin Jiang, Weilin Wang, Yanshan Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Immunology
Subjects:
Claudin 18.2
VHH
gastric cancer
pancreatic cancer
ADCC
CDC
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.885424/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.885424/full

Similar Items